Literature DB >> 8013628

Secretion of alpha 1-antitrypsin by alveolar epithelial cells.

P Venembre1, A Boutten, N Seta, M S Dehoux, B Crestani, M Aubier, G Durand.   

Abstract

We have investigated the ability of alveolar epithelial cells (human A549 cell line and rat type-II pneumocytes) to produce alpha 1-antitrypsin (AAT). Northern blot analysis demonstrated the presence of an AAT-specific mRNA transcript in A549 cells. Unstimulated A549 cells secreted immunoreactive AAT at a rate of 0.51 +/- 0.04 ng/10(6) cells/h, with a modified glycosylation compared to serum AAT. AAT formed a complex with neutrophil elastase. Rat type-II pneumocytes secreted immunoreactive AAT. Our results suggest that alveolar epithelial cells could participate in antiprotease defense within the lung through local AAT production.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8013628     DOI: 10.1016/0014-5793(94)80695-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  A novel model and molecular therapy for Z alpha-1 antitrypsin deficiency.

Authors:  Gillian L McNab; Timothy R Dafforn; Alice Wood; Elizabeth Sapey; Robert A Stockley
Journal:  Mamm Genome       Date:  2011-11-11       Impact factor: 2.957

Review 2.  The mysterious pulmonary brush cell: a cell in search of a function.

Authors:  Lynne Reid; Barbara Meyrick; Veena B Antony; Ling-Yi Chang; James D Crapo; Herbert Y Reynolds
Journal:  Am J Respir Crit Care Med       Date:  2005-04-07       Impact factor: 21.405

3.  Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma.

Authors:  G Akiri; M M Cherian; S Vijayakumar; G Liu; A Bafico; S A Aaronson
Journal:  Oncogene       Date:  2009-04-20       Impact factor: 9.867

4.  Oncostatin M induced alpha1-antitrypsin (AAT) gene expression in Hep G2 cells is mediated by a 3' enhancer.

Authors:  Kevin Morgan; Peter Marsters; Stephen Morley; Diana van Gent; Ala Hejazi; Matt Backx; Emma R K Thorpe; Noor Kalsheker
Journal:  Biochem J       Date:  2002-07-15       Impact factor: 3.857

5.  Sex-specific differences in emphysema using a murine antisense oligonucleotide model of α-1 antitrypsin deficiency.

Authors:  Rashika Joshi; Mohit Ojha; Jana Lewis; Qiang Fan; Brett Monia; Shuling Guo; Brian M Varisco
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-04-24       Impact factor: 5.464

Review 6.  Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

Authors:  Maria J Chiuchiolo; Ronald G Crystal
Journal:  Ann Am Thorac Soc       Date:  2016-08

7.  Tracheobronchial protease inhibitors, body surface area burns, and mortality in smoke inhalation.

Authors:  Margaret Kurzius-Spencer; Kevin Foster; Sally Littau; Karen J Richey; Beth M Clark; Duane Sherrill; Scott Boitano; Daniel M Caruso; Jefferey L Burgess
Journal:  J Burn Care Res       Date:  2009 Sep-Oct       Impact factor: 1.845

Review 8.  Proteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery.

Authors:  Catherine M Greene; Noel G McElvaney
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

9.  Differences in distribution and synthesis of the functional opponents alpha 1-proteinase inhibitor and neutrophil elastase in eukaryotic cells.

Authors:  E Davids; A Ogilvie
Journal:  Histochem Cell Biol       Date:  1995-09       Impact factor: 4.304

Review 10.  Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy.

Authors:  Joanna Wozniak; Tomasz Wandtke; Piotr Kopinski; Joanna Chorostowska-Wynimko
Journal:  Hum Gene Ther       Date:  2015-09-29       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.